2/12/2021: disclosing amyloid biomarker results in preclinical alzheimer's disease
Published 3 years ago • 608 plays • Length 1:01:26Download video MP4
Download video MP3
Similar videos
-
6:37
blood-based biomarkers as surrogates of amyloid burden in preclinical alzheimer's disease
-
21:11
safely disclosing amyloid results with alzheimer’s disease research participants
-
59:38
12/16/16: transforming alzheimer’s research and clinical care
-
39:29
the case for disclosing biomarker results to alzheimer’s research participants
-
36:39
multiplex immunoassay detection of alzheimer's disease biomarker
-
37:25
looking toward the future: how preclinical alzheimer’s disease biomarker disclosures impact society
-
1:00:09
under the hood: tracking preclinical alzheimer's disease with biomarkers
-
0:48
what is preclinical alzheimer's disease? 🧠
-
59:36
prashanthi vemuri - biomarkers, cognition and cognitive reserve in alzheimers disease
-
58:02
what advances in blood biomarker research could mean for the future of alzheimer's disease
-
3:19
prognostic blood biomarkers in the pre-clinical stages of alzheimer’s disease
-
1:57
phase iii ahead 3-45 trial of lecanemab for preclinical alzheimer’s disease
-
1:09:20
ad@uw april 23, 2021: imaging
-
53:24
deconstructing alzheimer’s disease complexity to identify resilience mechanisms
-
6:13
biomarkers for early detection of alzheimer’s disease: micrornas
-
1:07:18
csf biomarkers: aid in the differential diagnosisof alzheimer’s disease
-
53:00
dementia education i the who, what, where and when of alzheimer’s disease biomarker testing
-
27:32
sterling johnson
-
1:00:07
medicine grand rounds: alzheimer's biomarkers and emerging disease-modifying therapeutics 3/21/23